在从未吸烟者中,纳米技术为肺癌提供了精确疗法
Cristian Cojocaru1, Adina Magdalena Țurcanu1, Ruxandra Cojocaru1
1Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania.
Pharmaceutics
|February 27, 2026
概括
纳米技术通过克服药物输送障碍,增强了从未吸烟者肺癌的向治疗方法 (LCINS). 纳米载体提高了药物的有效性和特异性,解决了耐药性,从而改善了患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 纳米技术纳米技术
- 药理学 药理学是指药理学的学科.
背景情况:
- 从未吸烟者的肺癌 (LCINS) 是由特定的瘤原性改变驱动的,并且具有较低的瘤突变负担.
- 氨酸激酶抑制剂 (TKIs) 显示出初始的疗效,但面临的局限性包括药理动力学不佳,有限的中枢神经系统 (CNS) 透和耐药性.
- 在LCINS中的生物障碍包括低效的血管系统,密集的细胞外基质,排泄输送器和免疫抑制,通常由大脑转移复杂化.
研究的目的:
- 审查目前纳米技术在LCINS药物输送系统中的应用.
- 评估纳米载体如何克服生物障碍并增强向疗法.
- 探索改善对LCINS治疗反应的疗效和持续时间的策略.
主要方法:
- 使用PubMed和Web of Science (2022年1月至2025年11月) 进行了结构化的文献搜索.
- 审查的重点是研究详细说明纳米载体制备,物理化学性质和临床前模型中的治疗性能.
- 包括纳米载体治疗LCINS的药理动力学和临床结果的数据.
主要成果:
- 纳米载体平台可以提高药物溶解性,循环时间,并向瘤和中枢神经系统.
- 结合技术知识与核酸治疗的联合交付系统显示了调节多个途径和克服抵抗的潜力.
- 响应刺激的纳米载体为LCINS提供了先进的治疗策略.
结论:
- 纳米技术提供了一个有希望的方法来提高针对LCINS的向疗法的疗效和特异性.
- 克服生物障碍和抵抗机制对于改善治疗结果至关重要.
- 临床翻译需要优化的载体-有效载荷组合,可扩展的制造和生物标志物引导的患者选择.
更多相关视频
06:03Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
Published on: January 19, 2019
18.4K
11:31Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer
Published on: May 20, 2016
11.3K
相关概念视频
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
02:50Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K